| Application number | Title of the application | Filing Date | Status |
|---|
| 09/289535 | EXONS 4 AND 7 ENCODE SEPARATE TRANSACTIVATING AND CHROMATIN LOCALIZING DOMAINS IN ESX AND PROVIDE NOVEL TARGETS FOR MODULATORS OF ESX ACTIVITY | Apr 8, 1999 | Abandoned |
Array
(
[id] => 833392
[patent_doc_number] => 07396681
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2008-07-08
[patent_title] => 'Application of Hsp70 proteins'
[patent_app_type] => utility
[patent_app_number] => 09/646835
[patent_app_country] => US
[patent_app_date] => 1999-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 7320
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/396/07396681.pdf
[firstpage_image] =>[orig_patent_app_number] => 09646835
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/646835 | Application of Hsp70 proteins | Mar 28, 1999 | Issued |
| 09/273230 | PROTEIN FORMULATION | Mar 17, 1999 | Abandoned |
Array
(
[id] => 1109836
[patent_doc_number] => 06805865
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-10-19
[patent_title] => 'Compositions and methods for treating cancer and hyperproliferative disorders'
[patent_app_type] => B1
[patent_app_number] => 09/266543
[patent_app_country] => US
[patent_app_date] => 1999-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 16541
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/805/06805865.pdf
[firstpage_image] =>[orig_patent_app_number] => 09266543
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/266543 | Compositions and methods for treating cancer and hyperproliferative disorders | Mar 10, 1999 | Issued |
| 09/253439 | MODIFIED HEAT SHOCK PROTEIN-ANTIGENIC PEPTIDE COMPLEX | Feb 18, 1999 | Abandoned |
Array
(
[id] => 745740
[patent_doc_number] => 07026454
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-04-11
[patent_title] => 'Neuroendocrine marker of prostate cancer and method for producing same'
[patent_app_type] => utility
[patent_app_number] => 09/251133
[patent_app_country] => US
[patent_app_date] => 1999-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 10113
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/026/07026454.pdf
[firstpage_image] =>[orig_patent_app_number] => 09251133
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/251133 | Neuroendocrine marker of prostate cancer and method for producing same | Feb 15, 1999 | Issued |
| 09/216609 | METHODS OF ANTIBODY-DIRECTED ENZYME-PRODRUG THERAPY | Dec 20, 1998 | Abandoned |
Array
(
[id] => 1192062
[patent_doc_number] => 06730300
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2004-05-04
[patent_title] => 'Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications'
[patent_app_type] => B2
[patent_app_number] => 09/155106
[patent_app_country] => US
[patent_app_date] => 1998-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 11485
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/730/06730300.pdf
[firstpage_image] =>[orig_patent_app_number] => 09155106
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/155106 | Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody and use as a tumor vaccine and for targeting applications | Nov 16, 1998 | Issued |
Array
(
[id] => 1209160
[patent_doc_number] => 06713305
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2004-03-30
[patent_title] => 'Metastasis-associated antigen and antibodies thereto'
[patent_app_type] => B1
[patent_app_number] => 09/171991
[patent_app_country] => US
[patent_app_date] => 1998-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 25361
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 17
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/713/06713305.pdf
[firstpage_image] =>[orig_patent_app_number] => 09171991
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/171991 | Metastasis-associated antigen and antibodies thereto | Oct 22, 1998 | Issued |
Array
(
[id] => 5921131
[patent_doc_number] => 20020114804
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-22
[patent_title] => 'A METHOD OF TREATING INFECTION OF SUTURES AND PROSTHETIC DEVICES'
[patent_app_type] => new
[patent_app_number] => 09/177843
[patent_app_country] => US
[patent_app_date] => 1998-10-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 19
[patent_no_of_words] => 15287
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 84
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0114/20020114804.pdf
[firstpage_image] =>[orig_patent_app_number] => 09177843
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/177843 | A METHOD OF TREATING INFECTION OF SUTURES AND PROSTHETIC DEVICES | Oct 21, 1998 | Abandoned |
| 09/091711 | THERAPEUTIC COMPOSITIONS | Oct 15, 1998 | Abandoned |
| 09/114285 | RESHAPED HUMAN ANTIBODY TO HUMAN INTERLEUKIN-6 RECEPTOR | Jul 12, 1998 | Abandoned |
Array
(
[id] => 228547
[patent_doc_number] => 07601359
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2009-10-13
[patent_title] => 'Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins'
[patent_app_type] => utility
[patent_app_number] => 09/090754
[patent_app_country] => US
[patent_app_date] => 1998-06-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 19355
[patent_no_of_claims] => 44
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/601/07601359.pdf
[firstpage_image] =>[orig_patent_app_number] => 09090754
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/090754 | Compositions and methods for the prevention and treatment of primary and metastatic neoplastic diseases and infectious diseases with heat shock/stress proteins | Jun 3, 1998 | Issued |
| 09/079874 | REAGENTS AND METHODS USEFUL FOR DETECTING DISEASES OF THE URINARY TRACT | May 14, 1998 | Abandoned |
Array
(
[id] => 6278416
[patent_doc_number] => 20020107184
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2002-08-08
[patent_title] => 'METHOD FOR TREATING MELANOMA'
[patent_app_type] => new
[patent_app_number] => 08/964250
[patent_app_country] => US
[patent_app_date] => 1997-11-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1976
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0107/20020107184.pdf
[firstpage_image] =>[orig_patent_app_number] => 08964250
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/964250 | METHOD FOR TREATING MELANOMA | Nov 3, 1997 | Abandoned |
Array
(
[id] => 452685
[patent_doc_number] => 07247438
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2007-07-24
[patent_title] => 'Methods of identifying agents which enhance caspase activity'
[patent_app_type] => utility
[patent_app_number] => 08/948124
[patent_app_country] => US
[patent_app_date] => 1997-10-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 12
[patent_no_of_words] => 15017
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 145
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/247/07247438.pdf
[firstpage_image] =>[orig_patent_app_number] => 08948124
[rel_patent_id] =>[rel_patent_doc_number] =>) 08/948124 | Methods of identifying agents which enhance caspase activity | Oct 8, 1997 | Issued |
Array
(
[id] => 7612641
[patent_doc_number] => 06903194
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2005-06-07
[patent_title] => 'Antibody against human parathormone related peptides'
[patent_app_type] => utility
[patent_app_number] => 09/269332
[patent_app_country] => US
[patent_app_date] => 1997-09-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 36678
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/903/06903194.pdf
[firstpage_image] =>[orig_patent_app_number] => 09269332
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/269332 | Antibody against human parathormone related peptides | Sep 23, 1997 | Issued |
| 08/934845 | CELL GROWTH REGULATOR | Sep 21, 1997 | Abandoned |
| 08/919801 | CELL-FREE SYSTEM OF MITOCHONDRIA-DEPENDENT APOPTOSIS, AND METHODS OF USE THEREOF | Aug 28, 1997 | Abandoned |
Array
(
[id] => 7605207
[patent_doc_number] => 07115722
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2006-10-03
[patent_title] => 'Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers'
[patent_app_type] => utility
[patent_app_number] => 09/194164
[patent_app_country] => US
[patent_app_date] => 1997-05-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 20
[patent_no_of_words] => 27586
[patent_no_of_claims] => 49
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/115/07115722.pdf
[firstpage_image] =>[orig_patent_app_number] => 09194164
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/194164 | Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers | May 21, 1997 | Issued |